Cytek Biosciences, Inc. (CTKB)
NASDAQ · Healthcare
Cytek Biosciences, Inc. Net Income 2020–2025
Cytek Biosciences, Inc. annual/quarterly net income history and growth rate from 2020 to 2026. Net income is the total earnings of a company after all expenses, including taxes and interest, have been deducted from total revenues.
- Cytek Biosciences, Inc. net income for the quarter ending March 31, 2026 was -18.9 M, a 65.46% increase year-over-year.
- Cytek Biosciences, Inc. net income for the twelve months ending March 31, 2026 was -40.8 M, a 407.71% increase year-over-year.
- Cytek Biosciences, Inc. annual net income for 2025 was -66.5 M, a 1005.30% increase from 2024.
- Cytek Biosciences, Inc. annual net income for 2024 was -6.0 M, a 50.44% decrease from 2023.
- Cytek Biosciences, Inc. annual net income for 2023 was -12.1 M, a 589.05% decrease from 2022.
- Cytek Biosciences, Inc. annual net income for 2022 was 2.5 M.
Net Income
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Cytek Biosciences, Inc. Net Income — FAQ
Cytek Biosciences, Inc. (CTKB) net income over the last 6 years — annual and quarterly figures with year-over-year growth and charts.
What is Cytek Biosciences, Inc.'s net income?
Cytek Biosciences, Inc. (CTKB) reported net income of -$67M for fiscal 2025.
Where can I see CTKB's net income history?
The chart and table above show Cytek Biosciences, Inc.'s net income by year and by quarter, including the growth rate.